ALBENDAZOLE and RASH

Overview

RASH is the #9 most commonly reported adverse reaction for ALBENDAZOLE, manufactured by Amneal Pharmaceuticals LLC. There are 165 FDA adverse event reports linking ALBENDAZOLE to RASH. This represents approximately 1.7% of all 9,857 adverse event reports for this drug.

Patients taking ALBENDAZOLE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RASH is a less commonly reported adverse event for ALBENDAZOLE, but still significant enough to appear in the safety profile.

Other Side Effects of ALBENDAZOLE

In addition to rash, the following adverse reactions have been reported for ALBENDAZOLE:

• DRUG INEFFECTIVE — 365 reports
• OFF LABEL USE — 284 reports
• PYREXIA — 236 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 224 reports
• HEADACHE — 221 reports
• CONDITION AGGRAVATED — 212 reports
• FATIGUE — 166 reports
• WEIGHT DECREASED — 166 reports
• PAIN — 164 reports
• SOMNOLENCE — 159 reports

Other Drugs Associated with RASH

The following drugs have also been linked to rash in FDA adverse event reports:

Does ALBENDAZOLE cause RASH?

RASH has been reported as an adverse event in 165 FDA reports for ALBENDAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RASH with ALBENDAZOLE?

RASH accounts for approximately 1.7% of all adverse event reports for ALBENDAZOLE, making it a notable side effect.

What should I do if I experience RASH while taking ALBENDAZOLE?

If you experience rash while taking ALBENDAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages